Anna Lehman

4.8k total citations
77 papers, 1.3k citations indexed

About

Anna Lehman is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Anna Lehman has authored 77 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 27 papers in Genetics and 11 papers in Physiology. Recurrent topics in Anna Lehman's work include Genomics and Rare Diseases (16 papers), Genomic variations and chromosomal abnormalities (8 papers) and Lysosomal Storage Disorders Research (7 papers). Anna Lehman is often cited by papers focused on Genomics and Rare Diseases (16 papers), Genomic variations and chromosomal abnormalities (8 papers) and Lysosomal Storage Disorders Research (7 papers). Anna Lehman collaborates with scholars based in Canada, United States and Netherlands. Anna Lehman's co-authors include Sjaak Philipsen, Weihong Song, Weihui Zhou, Hong Qing, Millan S. Patel, Jan M. Friedman, Shelin Adam, Clara van Karnebeek, Christèle du Souich and Alison M. Elliott and has published in prestigious journals such as Circulation Research, Molecular and Cellular Biology and Neurology.

In The Last Decade

Anna Lehman

72 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Lehman Canada 20 579 462 211 125 109 77 1.3k
Felicitas Lacbawan United States 21 931 1.6× 565 1.2× 254 1.2× 212 1.7× 90 0.8× 50 1.8k
Caroline Sevin France 20 551 1.0× 268 0.6× 444 2.1× 120 1.0× 70 0.6× 54 1.4k
Sebastian Lunke Australia 22 789 1.4× 668 1.4× 119 0.6× 47 0.4× 104 1.0× 66 1.7k
Massimiliano Rossi France 22 583 1.0× 454 1.0× 247 1.2× 91 0.7× 46 0.4× 66 1.3k
Marina T. DiStefano United States 13 500 0.9× 567 1.2× 243 1.2× 60 0.5× 43 0.4× 27 1.4k
David A. Buchner United States 25 725 1.3× 240 0.5× 273 1.3× 116 0.9× 75 0.7× 44 1.4k
Aida M. Bertoli‐Avella Netherlands 21 611 1.1× 563 1.2× 154 0.7× 113 0.9× 241 2.2× 65 1.4k
Rongxi Yang China 15 1.5k 2.6× 209 0.5× 139 0.7× 70 0.6× 148 1.4× 55 1.8k
Juan L. Rodríguez-Flores United States 19 432 0.7× 386 0.8× 132 0.6× 87 0.7× 56 0.5× 29 1.1k
Aleš Maver Slovenia 20 506 0.9× 340 0.7× 157 0.7× 28 0.2× 82 0.8× 112 1.2k

Countries citing papers authored by Anna Lehman

Since Specialization
Citations

This map shows the geographic impact of Anna Lehman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lehman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lehman more than expected).

Fields of papers citing papers by Anna Lehman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lehman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lehman. The network helps show where Anna Lehman may publish in the future.

Co-authorship network of co-authors of Anna Lehman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lehman. A scholar is included among the top collaborators of Anna Lehman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lehman. Anna Lehman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Derralynn, Gere Sunder‐Plassmann, Ana Jovanović, et al.. (2024). Renal and multisystem effectiveness of 3.9 years of migalastat in a global real‐world cohort: Results from the followME Fabry Pathfinders registry. Journal of Inherited Metabolic Disease. 48(1). e12771–e12771. 7 indexed citations
2.
Boutin, Rozlyn C. T., et al.. (2024). Immune Dysregulation in a Child With SOD1 ‐Related Neurological Disease. American Journal of Medical Genetics Part A. 197(4). e63949–e63949.
3.
Vaseghi‐Shanjani, Maryam, Arezoo Mohajeri, Jill A. Rosenfeld, et al.. (2023). Dominant Negative Variants in IKZF2 Cause ICHAD Syndrome, a New Disorder Characterized by Immunodysregulation, Craniofacial Anomalies, Hearing Impairment, Athelia, and Developmental Delay. Clinical Immunology. 250. 109546–109546. 1 indexed citations
4.
Auray‐Blais, Christiane, Paméla Lavoie, Aneal Khan, et al.. (2023). Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy. Bioanalysis. 15(23). 1421–1437. 1 indexed citations
5.
Sage, Adam P., Hyun Kyung Lee, Susan Lin, et al.. (2023). Generation of tandem alternative splice acceptor sites and CLTC haploinsufficiency: A cause of CLTC‐related disorder. American Journal of Medical Genetics Part A. 191(8). 2219–2224.
6.
Richmond, Phillip A., Susan Lin, Kate L. Del Bel, et al.. (2022). Can tandem alternative splicing and evasion of premature termination codon surveillance contribute to attenuated Peutz–Jeghers syndrome?. American Journal of Medical Genetics Part A. 188(10). 3089–3095. 3 indexed citations
7.
Dragojlovic, Nick, Jan M. Friedman, Horacio Osiovich, et al.. (2022). The effect of rapid exome sequencing on downstream health care utilization for infants with suspected genetic disorders in an intensive care unit. Genetics in Medicine. 24(8). 1675–1683. 4 indexed citations
8.
Lin, Susan, Bhavi P. Modi, Kate L. Del Bel, et al.. (2022). Can leaky splicing and evasion of premature termination codon surveillance contribute to the phenotypic variability in Alkuraya-Kucinskas syndrome?. European Journal of Medical Genetics. 65(3). 104427–104427. 4 indexed citations
9.
Karnebeek, Clara van, Ellen Kim, Patricia Birch, et al.. (2019). The cost trajectory of the diagnostic care pathway for children with suspected genetic disorders. Genetics in Medicine. 22(2). 292–300. 34 indexed citations
10.
Myers, Angela, Christèle du Souich, Connie Yang, et al.. (2017). FOXP1 haploinsufficiency: Phenotypes beyond behavior and intellectual disability?. American Journal of Medical Genetics Part A. 173(12). 3172–3181. 20 indexed citations
11.
Jacquinet, Adeline, Debra Millar, & Anna Lehman. (2016). Etiologies of uterine malformations. American Journal of Medical Genetics Part A. 170(8). 2141–2172. 31 indexed citations
12.
Townsend, Katelin N., Casper Shyr, Allison Matthews, et al.. (2016). Optic atrophy, cataracts, lipodystrophy/lipoatrophy, and peripheral neuropathy caused by a de novo OPA3 mutation. Molecular Case Studies. 3(1). a001156–a001156. 10 indexed citations
13.
Roston, Thomas M., Wenting Guo, Andrew D. Krahn, et al.. (2016). A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia. Journal of Electrocardiology. 50(2). 227–233. 41 indexed citations
14.
Miyanji, Firoz, Christopher W. Reilly, Elena Lopez‐Rangel, et al.. (2015). BMPER variants associated with a novel, attenuated subtype of diaphanospondylodysostosis. Journal of Human Genetics. 60(12). 743–747. 11 indexed citations
15.
McGillivray, Barbara, et al.. (2015). A Clinical Classification Scheme for Tracheobronchomegaly (Mounier-Kuhn Syndrome). Lung. 193(5). 815–822. 20 indexed citations
16.
Lehman, Anna, André Mattman, Don D. Sin, et al.. (2012). Emphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assembly. Molecular Genetics and Metabolism. 106(1). 99–103. 15 indexed citations
17.
Lehman, Anna, Patrice Eydoux, D Doherty, et al.. (2010). Co‐occurrence of Joubert syndrome and Jeune asphyxiating thoracic dystrophy. American Journal of Medical Genetics Part A. 152A(6). 1411–1419. 27 indexed citations
18.
Lehman, Anna, Jan M. Friedman, David Chai, et al.. (2009). A characteristic syndrome associated with microduplication of 8q12, inclusive of CHD7. European Journal of Medical Genetics. 52(6). 436–439. 17 indexed citations
19.
Shrimpton, Antony E., R R Hoopes, Stephen J. Knohl, et al.. (2009). <i>OCRL1</i> Mutations in Dent 2 Patients Suggest a Mechanism for Phenotypic Variability. Nephron Physiology. 112(2). p27–p36. 73 indexed citations
20.
Schaefer, Deanna M. W., et al.. (2007). Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasia. Veterinary and Comparative Oncology. 5(3). 145–155. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felicitas Lacbawan Breakdown of academic impact, for papers by Caroline Sevin Breakdown of academic impact, for papers by Sebastian Lunke Breakdown of academic impact, for papers by Massimiliano Rossi Breakdown of academic impact, for papers by Marina T. DiStefano Breakdown of academic impact, for papers by David A. Buchner Breakdown of academic impact, for papers by Aida M. Bertoli‐Avella Breakdown of academic impact, for papers by Rongxi Yang Breakdown of academic impact, for papers by Juan L. Rodríguez-Flores Breakdown of academic impact, for papers by Aleš Maver
Rankless by CCL
2026